Vidcast: https://youtu.be/LsH7UZN_Fz4
Today’s medical discoveries that point to future therapy:
Ultrasonic Patch Warns Of Strokes and Heart Attacks
Electromagnetic Helmet Helps Shrink Brain Tumor
Copper Tranporter Gene Triggers Blood Vessel Repair
New Cancer Immunotherapy Emerging
Nanodressing Turbocharges Wound Healing
UC-San Diego have developed a soft, flexible ultrasound generating patch that, when worn on the skin of the neck or chest, can report blood flow problems major arteries feeding the brain and heart. The phased array of ultrasound transducers in the patch work continuously to measure blood flow in vessels as deep as 6 inches within the body. The ultrasound beam may also be electronically tilted for measurements of vessels not directly beneath the patch.
An oscillating magnetic field generated within a wearable helmet has driven shrinkage of an otherwise untreatable brain tumor by 30%. Neurosurgical investigators at the Houston Methodist Research Institute report the case of a 53 year old man with an end-stage, recurrent frontal lobe glioblastoma given this electromagnetic therapy for 5 weeks. Looks for more work in this arena.
Medical College of Georgia cardiologists report that the gene responsible for copper transport and utilization also promotes the healing of ailing blood vessels. In a biochemical cascade, the product of this gene, ATP7A, triggers activity of the blood vessel growth factor VEGFR2. Acquiring control over this process could help halt vascular deterioration in diabetics and others with chronic vascular disease.
There are new cancer immunotherapy agents in town called anti-TIGIT antibodies, and they prevent TIGIT from dialing down killer T cell activity against cancer cells. The major drug companies are all battling to get their hands on these experimental agents. GlaxoSmithKline just bought rights to EOS-448, BristolMyersSquibb bought AGEN1777, Gilead AB154, and Roche has already tested its tiragolumab in combination with another checkpoint inhibitor in phase 2 trials. Stay tuned on this one.
A wound nanodressing composed of thin threads of natural materials including collagen as well as wound healing promotion agents may provide a cost effective means of helping diabetics and others with chronic vascular disease. Michigan State bioengineers helmed a multinational group that has developed these dressings aiming to keep the eventual cost as low as $20 per unit by employing readily available biopolymers.
These and other cutting edge solutions are coming to your doctor’s office and our hospitals…….some day soon!
https://www.nature.com/articles/s41551-021-00763-4
https://www.frontiersin.org/articles/10.3389/fonc.2021.708017/full
https://www.nature.com/articles/s41467-021-23408-1
https://cen.acs.org/pharmaceuticals/biologics/GSK-buy-iTeosanti-TIGIT-antibody/99/i23
https: